<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>https://ecency.com</link><image><url>https://ecency.com/logo512.png</url><title>RSS Feed</title><link>https://ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Thu, 03 Sep 2026 13:51:26 GMT</lastBuildDate><atom:link href="https://ecency.com/created/mylan/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Mylan and Manchin]]></title><description><![CDATA[Brian Jeffries, Shinji Ayanami, and Nity discuss Mylan Inc and its connection to Joe Manchin.]]></description><link>https://ecency.com/@bohemiansummit/mylan-and-manchin</link><guid isPermaLink="true">https://ecency.com/@bohemiansummit/mylan-and-manchin</guid><category><![CDATA[mylan]]></category><dc:creator><![CDATA[bohemiansummit]]></dc:creator><pubDate>Sat, 10 Nov 2018 18:03:21 GMT</pubDate><enclosure url="https://i.ecency.com/p/S5Eokt4BcQdk7EHeT1aYjzebg2hC7hkthT45eRF84RhQ6eg6hqxxePGPeNiRyrFdmSxz22J?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Global Budesonide (BUD) Sales Market Size, Scope, Key Regions, Demand, Application, Upcoming Trends, Future and Forecast Till 2025]]></title><description><![CDATA[A newly compiled business intelligent report, titled “Global Budesonide (BUD) Sales Market Report 2018” has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study]]></description><link>https://ecency.com/@ashina/global-budesonide-bud-sales-market-size-scope-key-regions-demand-application-upcoming-trends-future-and-forecast-till-2025</link><guid isPermaLink="true">https://ecency.com/@ashina/global-budesonide-bud-sales-market-size-scope-key-regions-demand-application-upcoming-trends-future-and-forecast-till-2025</guid><category><![CDATA[pharmaceutical-industry]]></category><dc:creator><![CDATA[ashina]]></dc:creator><pubDate>Thu, 24 May 2018 09:41:27 GMT</pubDate></item><item><title><![CDATA[Increase in Aging Population Propelling Global Muscle Relaxants Market Steadily: Research Estimates 5.8% CAGR till 2022]]></title><description><![CDATA[In the present time, there are various muscle relaxer available on the market that is prescribed to treat a wide range of muscle pain in the body. Relaxant for the muscle is known to lower muscle pain]]></description><link>https://ecency.com/@ashina/increase-in-aging-population-propelling-global-muscle-relaxants-market-steadily-research-estimates-5-8-cagr-till-2022</link><guid isPermaLink="true">https://ecency.com/@ashina/increase-in-aging-population-propelling-global-muscle-relaxants-market-steadily-research-estimates-5-8-cagr-till-2022</guid><category><![CDATA[therapeutic-area]]></category><dc:creator><![CDATA[ashina]]></dc:creator><pubDate>Thu, 03 May 2018 07:11:42 GMT</pubDate></item><item><title><![CDATA[Self-Administered Medication Market: Hospital Pharmacies to Generate Significant Revenues]]></title><description><![CDATA[Fact.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. “Self-Administered Medication Market]]></description><link>https://ecency.com/@namratagupta/self-administered-medication-market-hospital-pharmacies-to-generate-significant-revenues</link><guid isPermaLink="true">https://ecency.com/@namratagupta/self-administered-medication-market-hospital-pharmacies-to-generate-significant-revenues</guid><category><![CDATA[healthcare]]></category><dc:creator><![CDATA[namratagupta]]></dc:creator><pubDate>Mon, 16 Apr 2018 10:28:03 GMT</pubDate></item><item><title><![CDATA[Prefilled Auto Injectors Industry Analysis with Growth Forecast during 2017-2022]]></title><description><![CDATA[Fact.MR has recently added a new report to its vast online database. This research study is titled as “Prefilled Auto Injectors Market Report” which presents an in-depth study about the production,]]></description><link>https://ecency.com/@andrewfact/prefilled-auto-injectors-industry-analysis-with-growth-forecast-during-2017-2022</link><guid isPermaLink="true">https://ecency.com/@andrewfact/prefilled-auto-injectors-industry-analysis-with-growth-forecast-during-2017-2022</guid><category><![CDATA[healthcare]]></category><dc:creator><![CDATA[andrewfact]]></dc:creator><pubDate>Thu, 18 Jan 2018 10:41:33 GMT</pubDate></item><item><title><![CDATA[Mylan finalizes $465 million EpiPen settlement]]></title><description><![CDATA[The drug manufacturer will pay $465 million for overcharging the US government for the EpiPen.]]></description><link>https://ecency.com/@illimattic/mylan-finalizes-usd465-million-epipen-settlement</link><guid isPermaLink="true">https://ecency.com/@illimattic/mylan-finalizes-usd465-million-epipen-settlement</guid><category><![CDATA[drug]]></category><dc:creator><![CDATA[illimattic]]></dc:creator><pubDate>Thu, 17 Aug 2017 18:32:27 GMT</pubDate><enclosure url="https://i.ecency.com/p/RGgukq5E6HBS5wvERDA3ZF4P2WKQy2VoZZet1QV2TJ1uJBCUbn91SF8eCofYfmJGW8y1a6npZcA236CimLGZveQvPwxkrFFPDvAkSiYvXafTKC81D1GAueBXaaGD4Kx?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[EpiPen maker faces revolt over exec's $98 million pay package]]></title><description><![CDATA[EpiPen maker Mylan is racing to put down a revolt from shareholders outraged by a $98 million pay package for its former CEO.]]></description><link>https://ecency.com/@xerxes612/epipen-maker-faces-revolt-over-exec-s-usd98-million-pay-package</link><guid isPermaLink="true">https://ecency.com/@xerxes612/epipen-maker-faces-revolt-over-exec-s-usd98-million-pay-package</guid><category><![CDATA[epipen]]></category><dc:creator><![CDATA[xerxes612]]></dc:creator><pubDate>Wed, 14 Jun 2017 00:07:09 GMT</pubDate><enclosure url="https://i.ecency.com/p/2gsjgna1uruvUuS7ndh9YqVwYGPLVszbFLwwpAYXYCXfG1iscLPEB1ABXPdhfHYCAfiZqh54wtRuvphRoJTxZiULGiyzZ4LmhwNFhbPQLKXGVVrHoL?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[The Robin Hood of Pharmacies brings cheaper EpiPens to America]]></title><description><![CDATA[Mylan Pharmaceuticals acquired the life-saving Epinephrine Auto-Injector, EpiPen in 2007 which is carried by people at risk for potentially life-threatening anaphylaxis. The EpiPen which has been around]]></description><link>https://ecency.com/@davejot/the-robin-hood-of-pharmacies-brings-cheaper-epipens-to-america</link><guid isPermaLink="true">https://ecency.com/@davejot/the-robin-hood-of-pharmacies-brings-cheaper-epipens-to-america</guid><category><![CDATA[medicine]]></category><dc:creator><![CDATA[davejot]]></dc:creator><pubDate>Thu, 01 Sep 2016 03:43:30 GMT</pubDate><enclosure url="https://i.ecency.com/p/7RYHp9W3SuhG7vuGA87TkiV2FHE4w?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[The makers of EpiPen killed their competition with the government's help]]></title><description><![CDATA[The pharmaceutical company Mylan was able to raise the price of EpiPens so ridiculously high because the government has been continually protecting it from its competitors. Its CEO is the daughter of Senator]]></description><link>https://ecency.com/@geke/the-makers-of-epipen-killed-their-competition-with-the-government-s-help</link><guid isPermaLink="true">https://ecency.com/@geke/the-makers-of-epipen-killed-their-competition-with-the-government-s-help</guid><category><![CDATA[corporatism]]></category><dc:creator><![CDATA[geke]]></dc:creator><pubDate>Sat, 27 Aug 2016 02:20:42 GMT</pubDate><enclosure url="https://i.ecency.com/p/5CEvyaAfMXajbT7xAVi1DPXmD5ar9JChAwGo5w7wR2qxHZbapWZo1yfXAFUJQd9S4HndtxDsFc2uhmQM4?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>